Litcius/Paper detail

Adherence in allergen immunotherapy: Current situation and future implications

Francesca Gehrt, Qingqing Xu, Ilaria Baiardini, Giorgio Walter Canonica, Oliver Pfaar

2022Allergologie select32 citationsDOIOpen Access PDF

Abstract

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.

Topics & Concepts

MedicineImmunotherapyAllergen immunotherapyAllergenIntensive care medicineClinical trialAllergyImmunologyDiseaseInternal medicineImmune systemAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchDermatology and Skin Diseases
Adherence in allergen immunotherapy: Current situation and future implications | Litcius